Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)

SHE:300255 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	61,540	18,372	11,957	5,036	7,472	5,693
Market Cap Growth	198.93%	53.65%	137.41%	-32.59%	31.26%	11.92%
Enterprise Value	63,841	20,352	14,091	6,817	8,617	6,631
Last Close Price	66.96	19.99	13.01	5.47	8.09	6.15
PE Ratio	-	-	-	287.58	31.99	22.52
Forward PE	-	12.44	12.44	12.44	12.44	12.44
PS Ratio	66.31	17.82	8.48	2.16	2.52	2.41
PB Ratio	41.62	11.96	6.64	1.65	2.43	2.00
P/TBV Ratio	50.74	14.65	8.02	1.80	2.68	2.20
P/OCF Ratio	1276.18	326.80	354.53	1611.41	2602.11	-
EV/Sales Ratio	68.79	19.74	9.99	2.92	2.90	2.81
EV/EBITDA Ratio	-	-	-	41.33	22.68	15.64
EV/EBIT Ratio	-	-	-	63.13	26.59	17.98
EV/FCF Ratio	-438.78	-	-	-	-	-
Debt / Equity Ratio	1.75	1.66	1.32	0.82	0.57	0.47
Debt / EBITDA Ratio	-	-	-	15.10	4.58	3.14
Asset Turnover	0.20	0.23	0.27	0.42	0.61	0.56
Inventory Turnover	0.62	0.62	0.85	0.56	0.60	0.45
Quick Ratio	0.24	0.25	0.29	0.72	0.52	0.67
Current Ratio	0.87	0.91	1.19	2.18	1.97	2.12
Return on Equity (ROE)	-18.04%	-15.83%	-51.43%	0.33%	7.81%	9.01%
Return on Assets (ROA)	-2.57%	-2.45%	-13.46%	1.20%	4.15%	5.41%
Return on Capital (ROIC)	-2.94%	-2.71%	-14.74%	1.30%	4.50%	5.94%
Return on Capital Employed (ROCE)	-8.50%	-7.70%	-42.80%	2.50%	9.40%	11.70%
Earnings Yield	-0.49%	-1.36%	-10.37%	0.35%	3.13%	4.44%
FCF Yield	-0.24%	-1.00%	-1.72%	-8.50%	-4.08%	-6.73%
Dividend Yield	-	-	-	0.09%	0.32%	-
Payout Ratio	-	-	-	708.02%	26.50%	27.08%
Buyback Yield / Dilution	-35.95%	-0.58%	-4.91%	6.27%	0.23%	0.24%
Total Shareholder Return	-35.95%	-0.58%	-4.91%	6.37%	0.55%	0.24%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.